1999-2004 Novo Nordisk, QC-lab Laboratory technician, Chemical and biological analysis
2004-2007 Novo Nordisk, Supporter Formulation of insulin products
2007-2010 Novo Nordisk, Special technician, Formulation of insulin products
2011-2012 Novo Nordisk, Special technician, Project coordinator, work package owner for formulation of insulin products
2012-2018 Novo Nordisk, Professional (formulation) Project manager, work package owner for formulation of hGH and hemophilia products.
2018- Novo Nordisk, Advanced MES analyst (PAS-X) in Global Novo Nordisk MES agile program.

Currently part of the Fill & Finish expansions project with focus on standardized and harmonized GMBRs for multiple site deployment.

1999-2004 Novo Nordisk, QC-lab Laboratory technician, Chemical and biological analysis
2004-2007 Novo Nordisk, Supporter Formulation of insulin products
2007-2010 Novo Nordisk, Special technician, Formulation of insulin products
2011-2012 Novo Nordisk, Special technician, Project coordinator, work package owner for formulation of insulin products
2012-2018 Novo Nordisk, Professional (formulation) Project manager, work package owner for formulation of hGH and hemophilia products.
2018- Novo Nordisk, Advanced MES analyst (PAS-X) in Global Novo Nordisk MES agile program.

Currently part of the Fill & Finish expansions project with focus on standardized and harmonized GMBRs for multiple site deployment.

1999-2004 Novo Nordisk, QC-lab Laboratory technician, Chemical and biological analysis
2004-2007 Novo Nordisk, Supporter Formulation of insulin products
2007-2010 Novo Nordisk, Special technician, Formulation of insulin products
2011-2012 Novo Nordisk, Special technician, Project coordinator, work package owner for formulation of insulin products
2012-2018 Novo Nordisk, Professional (formulation) Project manager, work package owner for formulation of hGH and hemophilia products.
2018- Novo Nordisk, Advanced MES analyst (PAS-X) in Global Novo Nordisk MES agile program.

Currently part of the Fill & Finish expansions project with focus on standardized and harmonized GMBRs for multiple site deployment.

Marianne Hansen worked for Novo Nordisk for 7 years initially as Filling Process supporter and Local PAS-X super user and designer. From 2021 as Advanced MES analyst in Global Novo Nordisk MES agile program. currently part of the central PAS-X CORE 3.3. project with focus on migration and deployment.

Marianne Hansen worked for Novo Nordisk for 7 years initially as Filling Process supporter and Local PAS-X super user and designer. From 2021 as Advanced MES analyst in Global Novo Nordisk MES agile program. currently part of the central PAS-X CORE 3.3. project with focus on migration and deployment.

Timoleon Hatzikyriazis has been an MES Expert and (G)MBR Designer at Boehringer Ingelheim for more than 10 years, currently responsible for the Werum PAS-X system.

After studying electrical engineering Martin Fusek's career started as a project engineer and later as a project manager and quality manager for MES at Propack Data GmbH. In 2005, he moved from the vendor to customer site and hold various IT management positions within Merckle Biotech and later in the Novartis group. In 2019 he took the role of Global Program Manager Manufacturing at Merck KGaA, before he joined Roche in 2021 as Head of Manufacturing IT.

Isabelle Sumera is 4+ years with ElevateBio where she holds the position as Senior Manager Operational Technology. In her work she supports the MES and LIMS teams, the greater OT team and the IT organization to maintain and enhance the systems. In her field of work she is dealing with MES- ERP interface, MES master recipes and LIMS support.

As Director Principal Consulting & Client Advisory, Michael Hasenauer and his team help customers in the pharma, biotech and cell & gene industries to define goals and strategies for their digital transformation journey using Körber's PAS-X portfolio and provide strategic consulting services during the various phases of global programs. Michael has 15 years of experience in various digitalization and digital transformation roles in the medical device and pharmaceutical industry. Prior to joining Körber, he spent 8 years at Novartis in different roles of increasing responsibility at local and global levels. He was responsible for the MES business project management for the pharmaceutical site Schaftenau in Austria, as well as for the harmonization and standardization of sterile manufacturing and packaging processes within the global aseptic network. Most recently, he was the Digital Product Owner for a global digital lighthouse program to build an insight center based on an advanced analytics ecosystem and user-centric digital solutions, e.g. to provide manufacturing sites with advanced analytics for real-time tactical decision making or economic order quantity simulation to optimize supply chain and manufacturing costs.

Thomas is a Principal Advisory Consultant in Manufacturing & Supply Chain at NNIT. His main area as consultant over the last 10 plus years in the industry have been different roles within MES Implementation projects, both single and core solutions, with recently the responsible MES Technical Lead for a highly automated launch facility developing & aligning with all partner systems new working concepts. His focus as an Advisor within NNIT is related to Process Analysis & Digitalization where the scope is not only to establish best practices but rather go ahead with new concepts using his capabilities as a thought leader.

Andreas Stamminger is responsible for strategic consulting for enterprise and IT architectures in digital manufacturing. This encompasses mainly the solution design for MES/MOM and IIoT.

There’s a technological shift within the industry motivated by the need to increase competitiveness and combat climate change. Both are seen as essential to an organization’s profitability, maybe even survival. My role is to help clients plan for this shift and execute it successfully.
I joined Accenture to help insert technology deeper into manufacturing and operations. This is the new frontier for innovation. The opportunities we have with Cloud and Edge computing, AI, and Digital Twins are what’s going to make the difference to how our companies—and our planet—thrive. Digital manufacturing contributes to a reduction in the waste of raw materials, energy and time, and results in fewer product errors. By providing workers with the right information at the right time, they can make better decisions.
My entire career has been in and around manufacturing. From leading strategy in IT, technology in OT, and in running a product line, I know it well. Currently, I’m most excited about the Digital Twin, and how it intersects with three key aspects of manufacturing: operations, technology and the business operating model. This is key as manufacturing is becoming ever more complex, and companies are finding it hard to keep up on all three fronts. My job is to bring these three aspects together and make them work for client organizations. That’s also my strength. I like to think of myself as the ultimate generalist.

Rebekah Cauthen is empowering Life Sciences Manufacturers with No-Code Apps. She is convinced that Data is the most valuable resource that manufacturers need to harvest.

Expertise: Architecture and Solution Design, Digital Transformation, Datacenter Consolidation and Migration, Enterprise Architecture, Private / Public / Hybrid cloud, Virtualization Portfolio Consultant including Network Functions Virtualization infra (NFVi), Application Migration, DevOps CI CD, Infrastructure Consulting, Dependency / Feasibility / TCO Analysis

We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat. We employ more than 55,000 people in 80 offices around the world, and market our products in 170 countries.

We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat. We employ more than 55,000 people in 80 offices around the world, and market our products in 170 countries.

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry nine years in a row by the Dow Jones Sustainability Indices (DJSI). The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2017 employed about 94,000 people worldwide. In 2017, Roche invested CHF 10.4 billion in R&D and posted sales of CHF 53.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit http://www.roche.com.

ElevateBio is a technology driven company powering transformative cell and gene therapies today and for many decades to come. The company has assembled industry-leading talent, built world-class facilities, and integrated diverse technology platforms necessary for rapid innovation and commercialization of cell, gene, and regenerative therapies. The company has built an initial technology stack, including gene editing, induced pluripotent stem cells, and protein, viral, and cellular engineering. At the center of the business model is ElevateBio BaseCamp, a centralized R&D and manufacturing company that offers research and development (R&D), process development (PD), and Current Good Manufacturing Practice (CGMP) manufacturing capabilities. The company is focused on increasing long-term collaborations with industry partners while also continuing to develop its own highly innovative cell and gene therapies. ElevateBio's team of scientists, drug developers, and company builders are redefining what it means to be a technology company in the world of drug development, blurring the line between technology and healthcare. ElevateBio is headquartered in Cambridge, Mass, with ElevateBio BaseCamp located in Waltham, Mass.

We are Körber – an international technology group with more than 12,000 employees at over 100 locations worldwide and a common goal: We turn entrepreneurial thinking into customer success and shape the technological change. In the Business Areas Digital, Pharma, Supply Chain, and Technologies, we offer products, solutions and services that inspire. We act fast to customer needs, we execute ideas seamlessly, and with our innovations we create added value for our customers. In doing so, we are increasingly building on ecosystems that solve the challenges of today and tomorrow. Körber AG is the holding company of the Körber Group. At the Körber Business Area Pharma we are delivering the difference along the pharma value chain with our unique portfolio of integrated solutions. With our software solutions we help drug manufacturers to digitalize their pharmaceutical, biotech and cell & gene therapy production. The Werum PAS-X MES Suite is recognized as the world’s leading Manufacturing Execution System for pharma, biotech and cell & gene. Our Werum PAS-X Savvy Suite accelerates product commercialization with data analytics and AI solutions and uncovers hidden business value. www.koerber-pharma.com

Whether it is the incremental improvements or the radical re-thinking of IT technology required to achieve advantage, innovation matters. In the German speaking countries, NNIT is based in Frankfurt (Germany) and Basel (Switzerland), thus in the center of a flourishing Life Sciences industry. We are well-known for our ability to bring inspiration and vision to life and to work with both IT and business groups to help them connect and transform data into valuable information. ​We are not just service providers and advisors; we are project managers, scientists, engineers, digital and data experts. We work in lab environments, clinical operations, regulatory affairs, manufacturing and supply chain and on system validation across the value chain. It is in this diverse mix, where we bring people and technology together, ideas are created, nurtured and delivered and the future of our Life Sciences clients is refined.

Accenture is a leading global professional services company that helps the world's leading businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services—creating tangible value at speed and scale. We are a talent- and innovation-led company with approximately 743,000 people serving clients in more than 120 countries. Technology is at the core of change today, and we are one of the world's leaders in helping drive that change, with strong ecosystem relationships. We combine our strength in technology and leadership in cloud, data and AI with unmatched industry experience, functional expertise and global delivery capability. We are uniquely able to deliver tangible outcomes because of our broad range of services, solutions and assets across Strategy & Consulting, Technology, Operations, Industry X and Song. These capabilities, together with our culture of shared success and commitment to creating 360° value, enable us to help our clients reinvent and build trusted, lasting relationships. We measure our success by the 360° value we create for our clients, each other, our shareholders, partners and communities. Visit us at www.accenture.com

Tulip, the leader in frontline operations, is empowering the world’s leading companies to improve the productivity of their teams, the quality of their output, and the efficiency of their operations. Companies use Tulip to digitally transform their operations and gain real-time visibility into the people, machines and processes involved in production—all in a matter of days. Companies of all sizes, across industries including consumer electronics, pharmaceuticals, aerospace and defense, contract manufacturing, automotive, apparel, medical devices and more, have implemented Tulip’s intuitive software and hardware platform to solve some of the most pressing challenges in frontline operations. Companies use Tulip to error-proof processes with guided workflows, integrate industrial IoT (IIoT) technologies with legacy machines, and capture and analyze real-time operations data.

Avanade Advisory helps leaders make the most of their investments by identifying and prioritising practical actions to embrace continual change and drive more business value from Microsoft ecosystem technologies. Our practitioners can help you ready your organisation for AI responsibly, make your technology investments work harder, monetise data, break down internal silos, manage change and meet your ESG goals.